InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: TheMonolith post# 345

Friday, 05/04/2018 9:07:27 AM

Friday, May 04, 2018 9:07:27 AM

Post# of 430
That response is intellectually lazy and doesn't even really warrant a response, he's comparing apples to bushel baskets for all I can tell.

He says "they have struggled with distribution domestically and abroad the product is also too expensive… Microbecare technology is better"

First off, has he seen Covalon's growth over the past year or so? I wouldn't call it a strugle, it's more like an inflection point, and Covalon has only just begun to hire sales and marketing people for the US market.

Secondly, the comparison to MicrobeCare really makes no sense based on a quick review of their website, which is apparently more effort than this person put into researching Covalon. Covalon makes advanced wound care products and coatings for implantable medical devices along with the other companies mentioned here, who have also been around for years: http://expressobserver.com/global-medical-device-coatings-market-2018-surmodics-inc-royal-dsm-biocoat-inc-coatings2go-llc-hydromer-inc-73146.html

From a brief review of MicrobeCare, it appears they make antimicrobial coatings for medical EQUIPMENT, like hospital beds and computer periphials. I do not see any evidence they are even involved in wound care products or implantable/interventional medical devices.


"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854